Oligodendroglioma other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Sujit Routray (talk | contribs)
No edit summary
Sujit Routray (talk | contribs)
Line 6: Line 6:


==Other Diagnostic Studies==
==Other Diagnostic Studies==
Fluorescent in-situ hybridization (FISH) technique - demonstrates deletions of [[chromosome 1|chromosome 1p]] and [[chromosome 19|19q]].<ref name=turk>{{Citation |last=Tihan |first=Tarik|last=Ersen|first=Ayca |year=2008 |title=Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007 |publisher=Turkish Journal of Pathology |publication-place= |page= |url=http://www.turkjpath.org/text.php3?id=645 |accessdate=9 October, 2015 }}</ref>
===Fluorescent in-situ hybridization (FISH) technique===
*FISH demonstrates deletions of [[chromosome 1|chromosome 1p]] and [[chromosome 19|19q]].<ref name=turk>{{Citation |last=Tihan |first=Tarik|last=Ersen|first=Ayca |year=2008 |title=Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007 |publisher=Turkish Journal of Pathology |publication-place= |page= |url=http://www.turkjpath.org/text.php3?id=645 |accessdate=9 October, 2015 }}</ref>


===Biopsy===
[[Biopsy]] demonstrates
*Biopsy may be of two types: [[craniotomy|open]] or [[stereotactic]].
*Indications of stereotactic biopsy include:
**Deep-seated [[tumor]] that is not amenable to resection
**Lesions in which the radiological and clinical findings are ambiguous
**Diffuse lesions; multiple lesions; an appearance that suggests a lymphoma, which would not require resection
**Change in the appearance of a previously diagnosed or treated tumor
**Assessment of tumor after treatment
*Biopsy may be done at the time of [[surgical resection]] of gliomatosis cerebri.
*Biopsy may be performed to help confirm the diagnosis of gliomatosis cerebri.


==References==
==References==

Revision as of 15:44, 12 October 2015

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma other diagnostic studies

CDC on Oligodendroglioma other diagnostic studies

Oligodendroglioma other diagnostic studies in the news

Blogs on Oligodendroglioma other diagnostic studies

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other Diagnostic Studies

Fluorescent in-situ hybridization (FISH) technique

Biopsy

Biopsy demonstrates

  • Biopsy may be of two types: open or stereotactic.
  • Indications of stereotactic biopsy include:
    • Deep-seated tumor that is not amenable to resection
    • Lesions in which the radiological and clinical findings are ambiguous
    • Diffuse lesions; multiple lesions; an appearance that suggests a lymphoma, which would not require resection
    • Change in the appearance of a previously diagnosed or treated tumor
    • Assessment of tumor after treatment
  • Biopsy may be done at the time of surgical resection of gliomatosis cerebri.
  • Biopsy may be performed to help confirm the diagnosis of gliomatosis cerebri.

References

  1. Ersen, Ayca (2008), Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007, Turkish Journal of Pathology, retrieved 9 October, 2015 Check date values in: |accessdate= (help)


Template:WikiDoc Sources